Intralesional Antimony for Single Lesions of Bolivian Cutaneous Leishmaniasis: Table 1. | Zendy

Jaime Soto | Zendy; Ernesto Rojas | Zendy; Miguel A. Guzmán | Zendy; Aleida Verduguez | Zendy; Winne Nena | Zendy; Maria Maldonado | Zendy; M. I. González Cruz | Zendy; Lineth Gracia | Zendy; Darsi Villarroel | Zendy; Isidoro Alavi | Zendy; Julia Toledo | Zendy; Jonathan Berman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intralesional Antimony for Single Lesions of Bolivian Cutaneous Leishmaniasis: Table 1.

Author(s) -

Jaime Soto,

Ernesto Rojas,

Miguel A. Guzmán,

Aleida Verduguez,

Winne Nena,

Maria Maldonado,

M. I. González Cruz,

Lineth Gracia,

Darsi Villarroel,

Isidoro Alavi,

Julia Toledo,

Jonathan Berman

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit049

Subject(s) - medicine , cryotherapy , placebo , lesion , adverse effect , cutaneous leishmaniasis , leishmania braziliensis , surgery , confidence interval , tolerability , target lesion , leishmaniasis , dermatology , gastroenterology , pathology , alternative medicine , percutaneous coronary intervention , myocardial infarction

Cutaneous leishmaniasis is an ultimately self-curing disease for which systemic therapy with pentavalent antimony (Sb) is effective but with side effects. We evaluated 2 local treatments, intralesional (IL) Sb and cryotherapy, for single lesions due to Bolivian Leishmania (v.) braziliensis in a placebo-controlled study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research